iBio, Inc. entered into a new Open Market Sale Agreement (ATM Agreement) with Jefferies LLC on February 27, 2026, for at-the-market offerings of up to $100,000,000 of common stock under a new S-3 registration statement. The company terminated its prior ATM Agreement with Chardan Capital Markets, LLC and Craig-Hallum Capital Group LLC on February 23, 2026.
Key takeaways
Entered ATM Agreement with Jefferies LLC on February 27, 2026, for sales of common stock up to $100,000,000
Termination notice given for Prior ATM Agreement on February 23, 2026, with Chardan Capital Markets, LLC and Craig-Hallum Capital Group LLC dated July 3, 2024
New offering pursuant to S-3 registration statement (File No. 333-293864) filed February 27, 2026
Prior ATM offering of up to $7,350,000 under S-3 (File No. 333-280680) terminated
Jefferies commission up to 3.0% of gross proceeds
Exhibit 1.1: Open Market Sale Agreement dated February 27, 2026